This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Higher bid: Walt Disney Co logo appears on a screen above the floor of the New York Stock Exchange. Thanks to Comcast’s late-stage competing bid that Disney was driven to pay nearly US20bil more than it originally intended to 21st Century Fox Inc. — AP
DISH CCV.CL CCV CMCSA TWX DTK NFLX CCZ TWC CMCSK DIS
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RHHVF RHHBY DTK RHHBF
CALGARY, Alberta, July 20, 2018 (GLOBE NEWSWIRE) -- Baytex Energy Corp. (TSX:BTE) (NYSE:BTE) ("Baytex") and Raging River Exploration Inc. (TSX:RRX) ("Raging River") are pleased to announce that they have filed a joint management information circular and proxy statement (the "Circular") for their respective special shareholders' meetings to be held in connection with the proposed strategic combination of Baytex and Raging River pursuant to a statutory plan of arrangement under the Business Corporations Act (Alberta) (the "Arrangement").
BTE RRENF DTK BTE RRX
Just when you thought it couldn’t get any worse for gold bugs, it has. Gold has sunk into a correction, and some forecast further downside to come.
WYOMISSING, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- Customers Bancorp, Inc. (NYSE:CUBI), the parent company of Customers Bank (collectively, “Customers”) today announced that it will host a conference call at 5:00 PM ET on Wednesday, July 25, 2018 to discuss its earnings results for the three months ending June 30, 2018. The second quarter 2018 earnings press release will be issued after market close that day.
CUBI.PRF CUBI DTK CUBS CUBI.PRC CUBI.PRD CUBI.PRE
MONACO, July 20, 2018 (GLOBE NEWSWIRE) -- Costamare Inc. (NYSE:CMRE), announced today that it will release its results for the second quarter ended June 30, 2018 after the market closes in New York on Tuesday, July 24, 2018.
CMRE.PRE CMRE.PRD CMRE.PRC CMRE CMRE.PRB DTK
WEST PALM BEACH, Fla., July 20, 2018 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform") announced today that it has signed a definitive agreement to sell its Agricultural Solutions business, which consists of Arysta LifeScience Inc. and its subsidiaries (collectively, “Arysta”), for $4.2 billion in cash to UPL Corporation Ltd., subject to customary closing conditions, adjustments and regulatory approvals.
PAH ESI DTK
HOUSTON, July 19, 2018 (GLOBE NEWSWIRE) -- Oil States International, Inc. (NYSE:OIS) announced today that it has scheduled its second quarter 2018 earnings conference call for Monday, July 30, 2018 at 10:00 am Central time. During the call, Oil States will discuss the results for the quarter ended June 30, 2018, which are expected to be released on July 30, 2018, before markets open.
DTK OIS OIS.WI
Microsoft sits close to record highs heading into its earnings report out Thursday evening. One technician sees more long-term upside from here.
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Och-Ziff Capital Management Group LLC (NYSE:OZM) ("Oz Management" or "Oz") will announce its 2018 second quarter results prior to the opening of the New York Stock Exchange on Thursday, August 2, 2018. Oz will host a conference call the same day at 8:30 a.m. Eastern Time to review these results. To access the call, please dial +1-866-393-4306 (in the U.S.
SEATTLE (AP) — Another big first for the marijuana industry is in the books: A major Canadian grower, processor and distributor has completed an initial public stock offering in the United States, raising $153 million, just as Canada prepares to legalize the drug nationwide.
TWMJF WEED DTK CGC
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to DTK / Deutsche Bank Contingent Capital Trust III on message board site Silicon Investor.
|Medtech Inc (MDTK)||MDTK-Medical Solutions for the Internet|
|idtk smartcard security finally perfected||Pacific Diagnostic Technologies (PDTK)|
as of ET